Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Instagram Outage Disrupts Thousands of U.S. Users 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Kolmar Korea, a Sejong City-headquartered pharmaceutical preparation manufacturing company, surpassed KRW2 trillion in annual sales for the first time since its founding in 1995. The company reached this milestone due to the immense growth of its subsidiary in China.
The company is looking to expand its market in the United States and will focus on its sunscreen products for this goal. Kolmar Korea can realize this plan as it has already laid the foundations for scaling up its business in the American market.
Targeting Bigger Market Share in the US
As per The Korea Times, Kolmar Korea is speeding up its market expansion in the U.S. market with its sunscreen products. The company prepared for this by obtaining product certification and setting up a new research and development center (R&D).
Kolmar Korea established the facility to better analyze the local consumer market and work on what is best to grow and expand to other regions. The company's primary target today is boosting the sales and demand for its sunscreen in the country since this will equate to success.
It was reported that the largest sunscreen developer in the country is targeting the U.S. because it has the most expansive market for sunscreens.
Big Sucess in China
Meanwhile, as it aims for U.S. expansion, the company is doing well in China. It hit KRW2 trillion in annual sales for the first time. Korea's Consumer News reported that Kolmar Korea said the main reason for the surge in sales was the growth of small and medium-sized indie brands in the country.
It was noted that the firm's ODM (Original Design Manufacturing) and OEM (Original Equipment Manufacturing) are remarkable and played prominent roles in raking in big sales in the territory. Kolmar Korea's Chinese subsidiary also accounts for the second-highest sales share after Korea, so the brand achieved a good performance in 2023.
"A potential for growth in the North American market, including the U.S., is limitless as sunscreen functions are incorporated not only in sunscreens but also in BB creams and foundations," a company official stated. "We plan to actively target the U.S., the world's No. 1 beauty market, not content with just holding a 70 percent share in the domestic sunscreen product market."
Photo by: Kolmar Website
